Clik here to view.
Novel antioxidant makes old arteries seem young again, study finds
Originally posted on lyranara.me: An antioxidant that targets specific cell structures—mitochondria—may be able to reverse some of the negative effects of aging on arteries, reducing the risk of heart...
View ArticleClik here to view.
Europe approves Pierre Fabre’s Hemangiol
Regulators in Europe have given the green light to Pierre Fabre’s Hemangiol for the treatment of proliferating infantile haemangioma. The European Commission has granted the French company...
View ArticleClik here to view.
FDA Approves Epanova (omega-3-carboxylic acids) for the Treatment of Severe...
FDA Approves Epanova (omega-3-carboxylic acids) for the Treatment of Severe Hypertriglyceridemia Tuesday, 6 May 2014 — AstraZeneca today announced that the US Food and Drug Administration (FDA) has...
View ArticleClik here to view.
(3S)-3-[[2-Amino-5-(2-methoxybenzyl)-5H-pyrrolo[3,2-d]pyrimidin-4-yl]amino]he...
COMPOUND 80 ABOVE IN http://www.google.com/patents/WO2014056953A1?cl=en (3S)-3-[[2-Amino-5-(2-methoxybenzyl)-5H-pyrrolo[3,2-d]pyrimidin-4-yl]amino]heptan-1-ol TLR7 Receptor Agonists , Signal...
View ArticleClik here to view.
(4aS,7aR)-1-[5-[(3-Fluorophenyl)ethynyl]pyridin-2-yl]hexahydrocyclopenta[d][1...
(4aS,7aR)-1-[5-[(3-Fluorophenyl)ethynyl]pyridin-2-yl]hexahydrocyclopenta[d][1,3]oxazin-2(1H)-one (4aS,7aR)-l-(5-Phenylethynyl-pyridin-2-yl)-hexahydro-cyclopenta[d] [l,3]oxazin-2-one 336.35 C20 H17 F...
View ArticleClik here to view.
IDX 18719; IDX 719; Samatasvir For HEPATITIS C in phase 2
IDX 18719; IDX 719; Samatasvir...
View ArticleClik here to view.
How to become a QP for Europe
Originally posted on DRUG REGULATORY AFFAIRS INTERNATIONAL: How to become a QP for Europe Both the ECA and the European QP Association are often contacted by people who would like to become a...
View ArticleClik here to view.
EMA publishes Guideline Draft on Validation of biotechnology-derived Products
Originally posted on DRUG REGULATORY AFFAIRS INTERNATIONAL: For the EMA, it was necessary to develop an independent guideline on the topic as – despite the existence of harmonised ICH documents –...
View ArticleClik here to view.
Researchers identify how heart stem cells orchestrate regeneration
Originally posted on lyranara.me: Investigators at the Cedars-Sinai Heart Institute – whose previous research showed that cardiac stem cell therapy reduces scarring and regenerates healthy tissue...
View ArticleClik here to view.
DASABUVIR, ABT 333 for the chronic Hepatitis C treatment.
DASABUVIR, ABT 333 1132935-63-7 Non-nucleoside NS5B polymerase inhibitor Methanesulfonamide, N-(6-(5-(3,4-dihydro-2,4-dioxo-1(2H)-pyrimidinyl)-3-(1,1-dimethylethyl)-2-methoxyphenyl)-2-naphthalenyl)-...
View ArticleClik here to view.
Buccal Drug Delivery Systems
Originally posted on The Global Innovations: The permeability of mucous membranes provides a convenient route for the systemic delivery of new and existing therapeutic drugs. Drug delivery through...
View ArticleClik here to view.
Team finds success with novel lung cancer treatment
Originally posted on lyranara.me: An old idea of retreating lung tumors with radiation is new again, especially with the technological advances seen in radiation oncology over the last decade. The...
View ArticleClik here to view.
Researchers develop antibody-targeted treatment for recurrent small-cell lung...
Originally posted on lyranara.me: Researchers at Norris Cotton Cancer Center have found an antibody that may be used in future treatments for recurrent small-cell lung cancer, which currently has no...
View ArticleClik here to view.
New combination therapy for hepatitis C
Originally posted on lyranara.me: A new combination therapy allows chronic hepatitis C to be treated in a manner that is less aggressive yet equally efficient. This is the result of a current study,...
View ArticleClik here to view.
FDA Approves Zontivity (vorapaxar) to Reduce the Risk of Heart Attacks and...
May 8, 2014 — The U.S. Food and Drug Administration today approved Zontivity (vorapaxar) tablets to reduce the risk of heart attack, stroke, cardiovascular death, and need for procedures to restore the...
View ArticleClik here to view.
GSK-1292263 Glucose-Dependent Insulinotropic Receptor (GDIR, GPR119) Agonists
GSK-1292263 1032823-75-8 3-isopropyl-5-(4-(((6-(4-(methylsulfonyl)phenyl)pyridin-3-yl)oxy)methyl)piperidin-1-yl)-1,2,4-oxadiazole...
View ArticleClik here to view.
MK-0822; Odanacatib……….has been identified as a potent and selective...
MK-0822; Odanacatib. 603139-19-1 Formula: C25H27F4N3O3S Mass: 525.17093 Merck Frosst Canada Ltd. phase 3...
View ArticleClik here to view.
Rucaparib, PF-01367338 for the treatment of patients with advanced ovarian...
Rucaparib, PF-01367338 283173-50-2 cas 6H-Pyrrolo[4,3,2-ef][2]benzazepin-6-one, 8-fluoro-1,3,4,5-tetrahydro-2-[4-[(methylamino)methyl]phenyl]- 6H-...
View ArticleClik here to view.
Tezacitabine
4-amino-1-[(2R,3E,4S,5R)-3-(fluoromethylidene)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidin-2-one 130306-02-4 Fmdc cpd, FMdC, MDL-101731, Mdl 101731, Mdl 101,731,...
View ArticleClik here to view.
Vibrant’s Vibrating Pill Shakes It Up as Promise for Chronic Constipation...
Originally posted on lyranara.me: Chronic constipation affects millions of people in the United States, which often results in visits to physician to get a prescription filed. The extremely...
View Article